Literature DB >> 29074921

EDITORIALS. Do cancer drugs improve survival or quality of life? 'Patient commentary: the current model has failed'.

.   

Abstract

The substantive paper in this issue states ( 2017;359: j4530) 'most drugs entered the market without evidence of benefit on survival or quality of life.'

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29074921     DOI： 10.1038/sj.bdj.2017.919

Source DB:  PubMed          Journal:  Br Dent J        ISSN： 0007-0610            Impact factor:   1.626


  3 in total

1.  Patient commentary: the current model has failed.

Authors:  Emma Robertson
Journal:  BMJ       Date:  2017-10-04

2.  Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.

Authors:  Robert L Ferris; George Blumenschein; Jerome Fayette; Joel Guigay; A Dimitrios Colevas; Lisa Licitra; Kevin Harrington; Stefan Kasper; Everett E Vokes; Caroline Even; Francis Worden; Nabil F Saba; Lara C Iglesias Docampo; Robert Haddad; Tamara Rordorf; Naomi Kiyota; Makoto Tahara; Manish Monga; Mark Lynch; William J Geese; Justin Kopit; James W Shaw; Maura L Gillison
Journal:  N Engl J Med       Date:  2016-10-08       Impact factor: 91.245

3.  Do cancer drugs improve survival or quality of life?

Authors:  Vinay Prasad
Journal:  BMJ       Date:  2017-10-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.